Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

2.3K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

256
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
256
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

2.5K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.5K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

521
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
521
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

180
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
180
Carbohydrate Metabolism01:36

Carbohydrate Metabolism

10.9K
Carbohydrates are polymers composed of molecules containing atoms of carbon, hydrogen and oxygen. One gram of carbohydrate can provide four kilo-calories of energy, which makes it the most efficient instant energy source.
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
10.9K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Using a Fine-Tuned Commercial Artificial Intelligence Model to Assess Nutrients from Photographs of Japanese Meals.

Journal of diabetes science and technology·2026
Same author

Digital Intervention Increasing Sleep Duration Among People With Type 2 Diabetes: Pilot Randomized Controlled Trial.

Journal of diabetes science and technology·2026
Same author

Research Code Sharing in Support of Gold Standard Science.

Journal of diabetes science and technology·2026
Same author

Efficacy of FiberMore, an AI-Based mHealth Intervention to Increase Dietary Fiber Intake Among Type 2 Diabetes Patients: Protocol for a Pilot Randomized Controlled Trial.

JMIR research protocols·2025
Same author

Dietary Fiber Estimate of DialBetesPlus App Users: Secondary Analysis of Data From a Randomized Controlled Trial.

JMIR formative research·2025
Same author

Elucidating Celecoxib's Preventive Effect in Capecitabine-Induced Hand-Foot Syndrome Using Medical Natural Language Processing.

JCO clinical cancer informatics·2025

相关实验视频

Updated: Jun 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K

用可解释的机器学习模型提高2型糖尿病治疗决策,用于预测血红蛋白A1c变化:机器学习模型开发.

Hisashi Kurasawa1,2, Kayo Waki2, Tomohisa Seki2

  • 1Nippon Telegraph and Telephone Corporation, Tokyo, Japan.

JMIR AI
|July 18, 2024
PubMed
概括

这项研究开发了一种机器学习模型,用于预测2型糖尿病 (T2D) 患者的低血糖控制. 该模型准确地识别了需要加强治疗的个体,改善了未来的健康结果.

关键词:
在这里,我们可以看到AIAIAI.人工智能的人工智能是人工智能.人们的注意力,重量,注意力.血糖控制 控制血糖的控制机器学习是机器学习.变压器变压器变压器变压器2 型糖尿病 2 型糖尿病

更多相关视频

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

574
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

764

相关实验视频

Last Updated: Jun 20, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.2K
Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model
06:22

Modeling and Evaluation of Murine Diabetic Cardiomyopathy Model

Published on: November 29, 2024

574
Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management
05:35

Author Spotlight: Developing a Point-of-Care Hemoglobin Estimation Method for Anemia Management

Published on: January 19, 2024

764

科学领域:

  • 生物医学信息学 生物医学信息学
  • 医疗保健中的机器学习
  • 糖尿病管理 糖尿病管理

背景情况:

  • 2型糖尿病 (T2D) 构成了全球重大健康挑战.
  • 预测未来的低血糖控制对于及时干预至关重要,但因季节性变化等因素而复杂化.
  • 医生需要工具来识别T2D患者在常规护理下低血糖控制的风险.

研究的目的:

  • 开发和验证标准护理中T2D患者血糖控制不良的预测模型.
  • 根据历史HbA1c趋势,准确预测未来低血糖控制 (HbA1c ≥8%) 的可能性.

主要方法:

  • 开发了一种机器学习模型,利用具有注意力机制的变压器架构.
  • 该模型处理不规则间隔的血红蛋白A1c (HbA1c) 时间序列数据以捕获时间关系.
  • 对7787名T2D患者的数据进行了模型性能评估,并与LightGBM模型进行了比较.

主要成果:

  • 拟议的模型实现了高预测精度,接收器操作特征曲线下的面积为0.925,精度回忆曲线下的面积为0.864.
  • 预测准确度与LightGBM模型的预测准确度相当或超过.
  • 该模型表明,最近的HbA1c水平是最有影响力的,而较旧的水平在预测低血糖控制方面略有优势.

结论:

  • 开发的模型准确地预测了T2D患者的低血糖控制在通常的护理下,包括那些接受治疗强化的人.
  • 医生可以使用这个模型来识别需要特殊治疗措施的患者.
  • 该工具还可以指导非专家将患者转诊给专家,当未来血糖控制不良时.